loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 20926 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 SEVELAMER HYDROCHLORIDE (1)

filter

01 GENZYME (1)

filter

01 CAPSULE;ORAL (1)

filter

01 403MG (1)

filter

01 USA (1)

URL Supplier Web Content
CAPSULE;ORAL
403MG
RENAGEL
USA
20926
1998-10-30
DISCN
Sanofi Company Banner

Cophex 2024

Not Confirmed

envelop Contact Supplier

Looking for CTD TGA MCC DOSSIER APPLICATION 20926

Looking for CTD TGA MCC DOSSIER APPLICATION 20926 1

19

Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

One of their notable products is SEVELAMER HYDROCHLORIDE, with a corresponding application number 20926 and regulatory information .

proudly manufactured in the

approval since 1998-10-30

Sanofi's RENAGEL CAPSULE;ORAL, medication with 403MG of SEVELAMER HYDROCHLORIDE.

Post Enquiry
POST ENQUIRY